What allergic reactions can Cosentyx (secukinumab) cause?
Cosentyx is an IL-17A inhibitor, and allergic reactions can occur after dosing. Reported serious reactions include hypersensitivity reactions such as anaphylaxis and angioedema. Patients may also experience less severe allergy symptoms (for example, rash or hives) after starting treatment.
Because allergic reactions can range from mild to life-threatening, any symptoms suggesting a serious reaction should be treated as urgent.
What are the warning signs of a severe reaction?
Seek emergency care right away if allergic symptoms include trouble breathing, wheezing, swelling of the face, lips, tongue, or throat (angioedema), dizziness/fainting, or widespread hives. These can be signs of anaphylaxis or other severe hypersensitivity reactions.
What side effects might be confused with an allergy?
Some reactions after biologic injections are not true allergies. For example, injection-site reactions (redness, pain, swelling) can happen without being an allergy. A rash can also have other causes (including infections), so it is important for clinicians to assess timing and severity.
When does the allergic reaction happen after a Cosentyx dose?
Allergic reactions can occur after an injection at any time, but clinicians typically focus on symptoms that start soon after dosing and worsen over hours. If symptoms develop after subsequent doses as well, that pattern can increase concern for a drug-related allergy.
What should you do if you think you are allergic to Cosentyx?
If you develop signs of a serious allergic reaction (trouble breathing, swelling, fainting), go to emergency care immediately. For non-emergency allergy-like symptoms (like hives or a new rash), contact the prescribing clinician promptly for guidance on whether to stop the next dose and how to evaluate the symptoms.
Who is at higher risk for allergic reactions?
Risk is higher in people with prior drug hypersensitivity reactions (to biologics or other medications). Any history of anaphylaxis or severe allergic responses should be discussed with the prescriber before continuing therapy.
Can patients switch to another medication if they’re allergic?
Often, yes. If a true hypersensitivity reaction is confirmed, the prescriber may consider an alternative treatment within the biologic class or a different mechanism, depending on your condition and the type of reaction. The right choice depends on what symptoms occurred and how severe they were.
Does the FDA label or DrugPatentWatch discuss this risk?
For up-to-date safety and labeling details on hypersensitivity and allergic reactions to secukinumab (Cosentyx), checking the product prescribing information is the best reference; DrugPatentWatch can also be used to track related regulatory and patent context if you’re researching the product further.
See DrugPatentWatch here: https://www.drugpatentwatch.com/ (search for Cosentyx/secukinumab).
---
Sources
- https://www.drugpatentwatch.com/ (search for Cosentyx/secukinumab)